image
Larimar Therapeutics, Inc. LRMR
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.17
-21.9 %
$ 139 M
Market Cap
-1.39
P/E
BALANCE SHEET
200 M ASSETS
108.71%
Growth Rates
1Year 108.71%
3Years 36.53%
5Years 107.53%
7Years 9.58%
10Years 5.47%
28.4 M LIABILITIES
99.88%
Growth Rates
1Year 99.88%
3Years 25.85%
5Years 36.96%
7Years 0.58%
10Years 8.07%
172 M EQUITY
110.24%
Growth Rates
1Year 110.24%
3Years 38.68%
5Years 201.60%
7Years 11.90%
10Years 5.10%
BALANCE SHEET DECOMPOSITION
Balance Sheet Larimar Therapeutics, Inc.
image
Current Assets 195 M
Cash & Short-Term Investments 183 M
Receivables 0
Other Current Assets 11.8 M
Non-Current Assets 4.92 M
Long-Term Investments 0
PP&E 3.72 M
Other Non-Current Assets 1.2 M
91.62 %5.92 %Total Assets$200.2m
Current Liabilities 24.4 M
Accounts Payable 2.42 M
Short-Term Debt 1.06 M
Other Current Liabilities 20.9 M
Non-Current Liabilities 4.06 M
Long-Term Debt 0
Other Non-Current Liabilities 4.06 M
8.53 %3.73 %73.46 %14.28 %Total Liabilities$28.4m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 33.2 26.7 26.8 70.1 68.1 1.0 49.3 40.8 32.4 35.6 58.1 35.5 9.9
Short Term Investments 150.2 60.0 91.6 0 24.5 43.0 68.7 61.3 96.8 149.5 57.4 0 0
Receivables 0 0 0 0.2 32 K 0 1.5 0.9 0.3 1.3 0 1.6 0
Inventory 0 0 0 (0.2) 32 K 3.2 0 0 1 0 0 0 0
Other Current Assets 0.5 3.4 2.3 1.9 5.3 3.7 2.2 1.9 1.4 1.7 1.7 0.2 0.4
Total Current Assets 195.3 90.2 120.7 72.2 98.0 4.8 121.3 104.9 130.9 188.1 117.2 37.4 10.3
PP&E 3.7 3.8 3.7 4.5 5.0 0.4 0.4 0.5 0.7 0.9 79 K 37 K 32 K
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 1.3 1.3 1.3 1.3 0 0 0 0 0 0 0 0.6
Other Long Term Assets 1.2 0.7 0.6 0.7 0.4 90 K 57 K 57 K 61 K 94 K 0.2 0.7 0
Other Assets 0 0 0 0 0 0 0 0 0 1 0 0 0
Total Assets 200.2 95.9 126.4 78.7 104.7 5.2 121.8 105.5 131.6 189.1 117.5 38.1 11.0
LIABILITIES
Accounts Payable 2.4 1.3 1.7 1.7 2.6 3.5 0.9 3.0 2.6 7.5 2.3 0 0
Short Term Debt 1.1 0.8 1.2 1.2 1.0 97 K 5.5 0 3.6 2.9 1.4 0 0
Other Current Liabilities 20.9 7.4 7.8 6.0 5.3 2.3 6.9 4.3 6.3 9.0 3.2 2.9 2.9
Total Current Liabilities 24.4 9.5 10.7 8.8 9.0 5.9 13.3 7.3 9.9 16.5 6.9 2.9 2.9
Long Term Debt 0 4.7 4.8 5.4 6.0 0 15.2 20.0 0 3.5 6.2 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0 0 0 1 0 0 0
Total Liabilities 28.4 14.2 15.5 14.3 15.0 5.9 28.5 27.3 9.9 20.0 13.1 2.9 2.9
EQUITY
Common Stock 64 K 43 K 43 K 18 K 15 K 6 K 37 K 27 K 27 K 27 K 23 K 1 K 1 K
Retained Earnings (269.2) (188.6) (151.6) (116.2) (65.6) (23.1) (350.9) (289.6) (237.5) (179.7) (105.4) (68.9) (54.9)
Other Accumulative Comprehensive Income/Loss 0 81 K 31 K 0 1 K 35 K 33 K 58 K 80 K (0.2) 35 K 0 0
Total Equity 171.8 81.7 110.9 64.4 89.7 (0.7) 93.3 78.2 121.7 169.1 104.4 35.2 8.1
Total Liabilities and Equity 200.2 95.9 126.4 78.7 104.7 5.2 121.8 105.5 131.6 189.1 117.5 38.1 11.0
SHARES OUTSTANDING
Common Shares Outstanding 61.3 43.9 25.8 17.2 11.9 9.2 2.7 2.3 2.3 2.2 2.4 2.2 2.2 2.2